← The Wire
NVAXNasdaq
NOVAVAX INC
Biological Products, (No Diagnostic Substances) · DE · CIK 1000694
Novavax develops vaccines and adjuvants to address global health challenges
$1.46B
Market cap
$9.36
Last close
+5.4%
1D
+4.0%
5D
4.0M
Volume
Price · last 39 sessions+16.6%
May 4L $8.03 · H $11.09Jun 29
344
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 6, 202610-Q10-QNov 6, 202510-Q10-QAug 6, 202510-Q10-QMay 8, 202510-Q10-QNov 12, 202410-Q10-QAug 8, 202410-Q10-QMay 10, 202410-Q10-QNov 9, 202310-Q10-QAug 8, 202310-Q10-QMay 9, 202310-Q10-QNov 9, 202210-Q10-QAug 9, 202210-Q10-QMay 10, 202210-Q10-QNov 5, 202110-Q10-QAug 5, 202110-Q10-QMay 10, 202110-Q10-QNov 10, 202010-QFORM 10-QAug 10, 202010-Q10-QMay 11, 202010-QFORM 10-QNov 7, 201910-QFORM 10-QAug 7, 201910-QFORM 10-QMay 2, 201910-QFORM 10-QNov 7, 201810-Q10-QAug 8, 201810-Q10-QMay 9, 201810-QFORM 10-QNov 7, 201710-QFORM 10-QAug 8, 201710-QFORM 10-QMay 8, 201710-QFORM 10-QNov 9, 201610-QFORM 10-QAug 9, 201610-QFORM 10-QMay 5, 201610-QFORM 10-QNov 9, 201510-QFORM 10-QAug 10, 201510-QFORM 10-QMay 7, 201510-QFORM 10-QNov 6, 201410-Q10-QAug 7, 201410-QQUARTERLY REPORTMay 8, 201410-QFORM 10-QNov 12, 201310-QFORM 10-QAug 8, 201310-QFORM 10-QMay 9, 201310-QFORM 10-QNov 9, 2012
In the News
Coverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance